Neal A DeLuca

Title: The Innovations of Neal A DeLuca

Introduction

Neal A DeLuca is a prominent inventor based in Cheswick, PA (US). He has made significant contributions to the field of virology, particularly in the development of herpes simplex virus (HSV) strains and vectors. With a total of 6 patents to his name, DeLuca's work has advanced our understanding of viral genetics and therapeutic applications.

Latest Patents

DeLuca's latest patents include innovative approaches to manipulating the HSV genome. One notable invention involves an HSV with a genome that has a mutation of a TAATGARAT sequence. This mutation allows for the expression of a native immediate early gene from the genome with delayed kinetics, contingent upon the presence of an ICP4 gene product. Another significant patent focuses on HSV vectors, which are designed to express a native immediate early gene with delayed kinetics in the presence of the ICP4 gene product. This invention also includes a method for expressing a polynucleotide within a cell by infecting it with the modified HSV.

Career Highlights

Throughout his career, DeLuca has worked with esteemed institutions such as the University of Pittsburgh and Harvard College. His research has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in treating viral infections.

Collaborations

DeLuca has collaborated with notable colleagues, including Kai Xia and David M Knipe. These partnerships have enhanced the scope and impact of his research in the field of virology.

Conclusion

Neal A DeLuca's innovative work in the realm of herpes simplex virus research exemplifies the importance of scientific inquiry and collaboration. His contributions continue to influence the field and hold promise for future advancements in viral therapies.